Cargando…
Molecular mechanism of CD163(+) tumor-associated macrophage (TAM)-derived exosome-induced cisplatin resistance in ovarian cancer ascites
BACKGROUND: Studies have found that tumor-associated macrophages (TAMs) in the malignant ascites of patients with serous ovarian cancer exhibit a mixed polarization phenotype and highly variable expression of the surface marker CD163. The exosomes secreted by mesenchymal cells can be taken up by tum...
Autores principales: | Zhang, Xiaohui, Wang, Jiapo, Liu, Na, Wu, Weimin, Li, Hong, Chen, Jinhong, Guo, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577761/ https://www.ncbi.nlm.nih.gov/pubmed/36267748 http://dx.doi.org/10.21037/atm-22-4267 |
Ejemplares similares
-
The Clinical Significance of CD163+ Tumor-Associated Macrophages (TAMs) in Laryngeal Squamous Cell Carcinoma
por: Ouban, Abderrahman, et al.
Publicado: (2023) -
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
por: Reinartz, Silke, et al.
Publicado: (2014) -
CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects
por: Yang, Zun, et al.
Publicado: (2023) -
Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
por: Etzerodt, Anders, et al.
Publicado: (2019) -
Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
por: Yin, Meichen, et al.
Publicado: (2019)